[Medical therapy of portal hypertension due to liver cirrhosis].
Several vasoactive agents are known to reduce portal pressure and therefore are potentially useful in the treatment of portal hypertension. These drugs act in different ways and seem to have several actions. In most cases, their exact mechanisms have not yet been elucidated and more investigations are required. Different pharmacologic treatments of portal hypertension may result from these hemodynamic studies but more trials are required in the forthcoming years.
Cerini
R
R
Istituto di Medicina socio-territoriale, II Facoltà di Medicina, Università, Napoli.
Sperandeo
M
M
Varriale
A
A
De Rosa
M L
ML
Cacciatore
L
L
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008102:Liver Circulation / Q000187:drug effects / Q000502:physiology; D008103:Liver Cirrhosis / Q000150:complications* / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
Terapia medica dell'ipertensione portale da cirrosi epatica.